
Current Price | $0.45 | Mkt Cap | $101.2M |
---|---|---|---|
Open | $0.47 | P/E Ratio | -0.91 |
Prev. Close | $0.45 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.42 - $0.48 | Volume | 9,472 |
52-Wk Range | $0.42 - $2.38 | Avg. Daily Vol. | 416,849 |
Current Price | $0.45 | Mkt Cap | $101.2M |
---|---|---|---|
Open | $0.47 | P/E Ratio | -0.91 |
Prev. Close | $0.45 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.42 - $0.48 | Volume | 9,472 |
52-Wk Range | $0.42 - $2.38 | Avg. Daily Vol. | 416,849 |
The best Bull and Bear pitches based on recency and number of recommendations.
Adaptimmune is another addition for zzporte's basket of CAR-T/affinity-enhanced TCR immunotherapy stocks that already includes Juno, Kite, and Bellicum in the US and others in Europe. I don't think we have any enormous insight into this recent IPO,… More
My wife gets mad if we put the milk back in the fridge with only one sip left which is weird based on all her 96% empty shampoo bottles.
Read the most recent pitches from players about ADAP.
Recs
Different from the other T-CARs next year expanding away from oncology into other areas.....this is no one trick pony.
Recs
good
Recs
Adaptimmune is another addition for zzporte's basket of CAR-T/affinity-enhanced TCR immunotherapy stocks that already includes Juno, Kite, and Bellicum in the US and others in Europe. I don't think we have any enormous insight into this recent IPO, but I do like the fact that they are already in clinical trials and the lead candidate is partnered with GSK. Our 400 shares at 19.01 value the company at over a billion, but of course if the technology works that will seem relatively low. Success from one of the more advanced companies like Juno may also exert a bootstrap effect on the earlier stage outfits.
Find the members with the highest scoring picks in ADAP.
sln (47.31) Score: +217.13
The Score Leader is the player with the highest score across all their picks in ADAP.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
svenof | 53.76 | 12/1/2015 |
![]() |
5Y | $9.26 | -95.18% | +116.79% | +211.97 | 0 Comment | |
capstrarian | 81.70 | 1/29/2019 |
![]() |
5Y | $4.67 | -90.45% | +72.65% | +163.10 | 0 Comment | |
sln | 47.31 | 4/5/2021 |
![]() |
5Y | $5.63 | -92.08% | +12.76% | +104.83 | 0 Comment | |
TRM4 | < 20 | 3/7/2022 |
![]() |
5Y | $1.98 | -77.47% | +7.54% | -85.01 | 0 Comment | |
![]() |
ak1010 | 99.63 | 11/3/2022 |
![]() |
5Y | $1.50 | -70.26% | +22.47% | -92.73 | 0 Comment |
Playa17 | < 20 | 11/3/2022 |
![]() |
5Y | $1.50 | -70.26% | +22.47% | -92.73 | 0 Comment | |
foggs1 | 48.69 | 3/17/2021 |
![]() |
5Y | $5.20 | -91.42% | +15.31% | -106.73 | 0 Comment | |
staebsstreet | 21.70 | 1/26/2021 |
![]() |
5Y | $5.54 | -91.95% | +18.41% | -110.35 | 0 Comment | |
odocoileus | < 20 | 11/9/2020 |
![]() |
5Y | $5.16 | -91.35% | +26.42% | -117.78 | 0 Comment | |
quinpeung | 34.73 | 11/13/2020 |
![]() |
5Y | $4.80 | -90.71% | +28.05% | -118.76 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.